Is this you? Create Your Porfile
Avatar

Falk Eugen

Aventis Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Falk Eugen is active.

Explore More

Publication

Featured researches published by Falk Eugen.

Archive | 1997

VERWENDUNG VON INHIBITOREN DES ZELLULÄREN Na?+ /H?+ -EXCHANGERS (NHE) ZUR HERSTELLUNG EINES MEDIKAMENTS ZUR NORMALISIERUNG DER SERUMLIPIDE

Lang Hans Jochen; Jansen Hans-Willi; Schwark Jan-Robert; Kleemann Heinz-Werner; Jung Oliver; Schaefer Hans-Ludwig; Linz Wolfgang; Kramer Werner; Schoelkens Bernward; Falk Eugen

Archive | 2000

Verwendung von bissulfonamiden zur herstellung von medikamenten zur prophylaxe oder behandlung von hyperlipidämie

Kirsch Reinhard; Schaefer Hans-Ludwig; Falk Eugen; Krass Norbert

Archive | 2008

6-OXAZOL-4-YLMETHOLMETHOXY-ALKO-ALKOXYMETHYL SUBSTITUTED BENZOIC ACID DERIVATIVES FORMING PEROXISOME PROLIFERATOR - ACTIVATED RECEPTOR (PPAR) LIGANDS, PROCESS FOR THEIR PREPARATION AND METHODS OF USE THEREOF

Stapper Christian; Glombik Heiner; Falk Eugen; Keil Stefanie; Schaefer Hans-Ludwig; Wendler Wolfgang; Hachtel Stephanie

Archive | 1998

HYPOLIPIDAEMIC 1,4-BENZOTHIAZEPINE-1,1-DIOXIDES

Enhsen Alfons; Falk Eugen; Glombik Heiner; Stengelin Siegfried

Archive | 2015

sulfonamidas n-heterocíclicas reforçadas com grupo principal de oxadiazolona, processos para sua preparação e seu uso como farmacêuticos

Falk Eugen; Matter Hans; Glien Maike; Urmann Matthias; Keil Stefanie; Wendler Wolfgang

Archive | 2013

DERIVADOS DE SULFONIL-FENIL-2H-(1,2,4)OXADIAZOL-5-ONAS, PROCESSOS PARA SUA PREPARAÇÃO E SEU USO COMO FARMACÊUTICOS

Keil Stefanie; Urmann Matthias; Schoenafinger Karl; Wendler Wolfgang; Glien Maike; Schaefer Hans-Ludwig; Falk Eugen

Archive | 2011

Sulfonamides n-hétérocycliques annelés avec un groupe de tête oxadiazolone, procédés pour leur préparation et leur utilisation en tant qu'agents pharmaceutiques

Keil Stefanie; Urmann Matthias; Wendler Wolfgang; Glien Maike; Matter Hans; Falk Eugen

Archive | 2011

VERWENDUNG VON PPAR AGONISTEN ZUR BEHANDLUNG VON HERZVERSAGEN

Linz Wolfgang; Schaefer Stefan; Falk Eugen; Schaefer Hans-Ludwig

Archive | 2010

2-{-3-2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy)-propionsyrederivater som PPAR-ligander (peroxisomen-proliferator-aktiverede receptorer) til behandling af hyperlipidæmi og diabetes

Glombik Heiner; Stapper Christian; Falk Eugen; Keil Stefanie; Schaefer Hans-Ludwig; Wendler Wolfgang; Knieps Stephanie

Archive | 2010

PIRROLIDIN SULFONAMIDAS ANELADAS CON GRUPO DE CABEZA DE OXADIAZOLONA, PROCESOS PARA SU PREPARACIÓN Y SU USO COMO SUSTANCIAS FARMACÉUTICAS

Matter Hans; Falk Eugen; Keil Stefanie; Urmann Matthias; Glien Maike; Wendler Wolfgang

Explore More

Collaboration

Dive into the Falk Eugen's collaboration.

Top Co-Authors
Avatar

Glombik Heiner

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Schaefer Hans-Ludwig

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Keil Stefanie

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Wendler Wolfgang

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Stapper Christian

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Goerlitzer Jochen

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Gretzke Dirk

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Enhsen Alfons

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Kramer Werner

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Jansen Hans-Willi

Aventis Pharma

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge